Status:
COMPLETED
Dietary Therapy in Dialysis Patients
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
Patients with end-stage kidney disease have hyperphosphatemia and accumulated uremic toxin level due to decreased urine excretion ability. Unhealthy diet causes altered mineral metabolism, elevated ur...
Detailed Description
The risk of cardiovascular disease (CVD) and mortality in patients with end-stage kidney disease (ESKD) is far greater than those in the general population. Emerging evidence suggests that unhealthy d...
Eligibility Criteria
Inclusion
- Subjects with aged older than 20 years, ESKD undergoing maintenance dialysis for more than three months, having adequate dialysis, serum intact parathyroid hormone less than 800 pg/mL and good dietary compliance
Exclusion
- Patients who meet any of the following criteria will be excluded from the study:
- Serum albumin level less than 2.5 g/dL
- Hospitalization within the past 4 weeks
- Prebiotics, probiotics, symbiotics or antibiotics use within the past 4 weeks
- History of psychiatric disorders
- Having mental retardation
- Those who dislike of the study meals
- Soft diet requirement
- Vegetarian
Key Trial Info
Start Date :
October 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04505462
Start Date
October 28 2020
End Date
March 1 2022
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan